Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Mologic Gets CE Mark for Infection Dx

Mologic Gets CE Mark for Infection Dx

Jun 14, 2017
|
staff reporter

NEW YORK (360Dx) – British diagnostics firm Mologic today said that it has received CE marking for its Periplex point-of-care test for detection of infections in patients undergoing peritoneal dialysis.

The company said that it also has launched the test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Infectious Disease

  1. BD Gets CE-IVD Mark for Point-of-Care Coronavirus Antigen Test

  2. US to Distribute 150 Million Abbott SARS-CoV-2 Antigen Tests at No Cost

  3. BARDA Exercises $10.5M Option on T2 Bio Contract

  4. Fluidigm Finalizes $34M NIH Contract for SARS-CoV-2 Assay Production

  5. Access Genetics Nabs Amended FDA Emergency Use Authorization for Oral Rinse SARS-CoV-2 PCR Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.